Centene Finds Profit Growth Even as Medicaid Membership Softens
Centene beat Q2 earnings and revenue estimates, raised its 2026 outlook, improved medical cost trends, and reported lower Medicaid membership.
Read original at benzingaStocks · News reference
Truist Securities analyst David Macdonald maintains Molina Healthcare (NYSE:MOH) with a Hold and lowers the price target from $250 to $225.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Centene beat Q2 earnings and revenue estimates, raised its 2026 outlook, improved medical cost trends, and reported lower Medicaid membership.
Read original at benzingaWells Fargo analyst Stephen Baxter maintains Molina Healthcare (NYSE:MOH) with a Equal-Weight and lowers the price target from $235 to $220.
Read original at benzinga